Navigating the Shift: What the 2026 State of the Union Means for the Lupus Community

Keeping up with healthcare policy can feel like a full-time job—especially when you’re already managing a complex condition like lupus. President Trump’s 2026 State of the Union (SOTU) address, while focused heavily on the economy and trade, carved out a specific vision for healthcare that could significantly shift how chronic illness is managed in America.

For the lupus and chronic illness community, the speech offered a mix of promising new initiatives and some "wait-and-see" moments regarding insurance and drug costs. Here are the four key takeaways you need to know.

1. The "Make America Healthy Again" (MAHA) Expansion

One of the most visible themes of the night was the expansion of the MAHA initiative, led by HHS Secretary Robert F. Kennedy Jr. While much of the early focus was on childhood health, the SOTU signaled a pivot toward addressing the "root causes" of adult chronic and autoimmune diseases.

• Environmental & Food Focus: The administration is doubling down on removing artificial dyes and chemicals from the food supply. For lupus patients—many of whom manage systemic inflammation through diet—a cleaner food supply could be a helpful suggestion and positive structural change. However, this hyperfocus on "clean eating" can become compulsive. In fact, there has been an increase in cases of Orthorexia, which is an eating disorder characterized by an obsessive focus on healthy or "clean" eating. As Dietician Beth Francois states, "Unlike other eating disorders, orthorexia is primarily driven by an extreme preoccupation with the quality and purity of food, as opposed to weight & body image preoccupation. It may be confusing to understand how a focus on 'health' can be considered an illness. Still, the obsessive nature of orthorexia means eating patterns can become highly restrictive, resulting in potential serious physical and psychological health consequences". The ED Dietician

  
  

• Invisible Illnesses: The President highlighted new roundtables focused on "invisible" illnesses like Long COVID and Lyme disease. While lupus wasn't mentioned by name, the focus on the "autoimmune epidemic" suggests a broader federal interest in conditions that have historically been difficult to diagnose and treat. This is good, since lupus has been overlooked and underfunded for most of history. Time will tell if it gets the funding and attention it deserves.

2. "TrumpRx" and Drug Pricing

Drug costs are a primary concern for anyone on a regimen of immunosuppressants or biologics. The President touted his "Most Favored Nation" (MFN) pricing policy, which aims to ensure Americans pay the lowest price in the world for certain medications.

• The TrumpRx Portal: The administration has launched a direct-to-consumer website to help patients find lower prices on brand-name drugs.

  
  

• The Catch: Critics and health experts note that while these deals have lowered prices for some specific drugs (like fertility treatments and some insulin types), several specialty medications used in lupus care are not yet covered under these international pricing agreements. Many SLE lupus treatments fall under or near this category; they may be shielded from the very price-slashing the President promised, leaving patients stuck with high costs while other "common" drugs get cheaper.

• Critical Advice for the Lupus Community: While the headlines promise "the lowest prices in the world," the reality is more nuanced for patients with private insurance.

  • Insurance vs. Cash: If you have private insurance with a low copay, you likely already pay less than the "TrumpRx" price. These new portal prices are designed primarily to help people who are paying the full list price out-of-pocket.

  • The Tariff Trade-Off: In exchange for lowering these prices, drugmakers like GSK, AstraZeneca, and J&J received exemptions from new tariffs. This suggests that the current lower prices are stable for the next three years, providing some much-needed predictability for your medical budget.

  • The "One Big Beautiful Bill" Trap: Be careful with plans that shift you toward a high-deductible HSA. While you may get "transparency," you could end up paying the full MFN price (which is still hundreds or thousands for biologics) until your deductible is met.

3. Big Changes to Insurance & Medicaid

This is where the landscape gets more complex. The speech touched on the "One Big Beautiful Bill Act," which introduced significant reforms to federal healthcare programs.

• Direct Payments vs. Insurance: Trump proposed moving away from paying "big insurance companies" and instead giving that money directly to individuals via Health Savings Accounts (HSAs) to buy their own care.

  
  

• Medicaid Restructuring: The new law introduces stricter eligibility checks and work requirements for some Medicaid recipients. If you rely on Medicaid, it is more important than ever to ensure your disability status is properly documented, as those with verified disabilities are generally exempt from these new work requirements.

• Important note: At the end of 2025, the enhanced premium tax credits that made Marketplace plans affordable for middle-income families... were allowed to expire.

  • For many in the lupus community who don't qualify for Medicaid but can't work a traditional 9-to-5 with benefits, net premiums are projected to rise by an average of 75% in 2026.

  • WARNING: If you can't afford the new premiums, you may be forced into "junk plans"—short-term insurance that is cheaper but often excludes coverage for pre-existing conditions or expensive biologics like Benlysta.

4. Radical Transparency in Medical Costs

A major win for the community is the push for "Radical Transparency." HHS is now requiring hospitals and insurers to provide clear, upfront pricing that a human can actually understand—not a string of medical codes.

• The Trap: While saving money sounds good, lupus care is astronomically expensive. A direct payment or a tax credit might cover a few months of labs, but it won't cover a $40,000-a-year biologic or a week-long hospital stay for a kidney flare.

  
  

What Should You Do Now?

The healthcare landscape is shifting from a "managed care" model to a "consumer-driven" one. Here is how to stay ahead:

1. Audit Your Coverage: With the expiration of some ACA subsidies and the rise of new HSA-based plans, check with your provider to see if your current plan is still the most cost-effective. If you are considering a new HSA-style plan, don't just look at the premium. Calculate the Maximum Out-of-Pocket limit, as a person with lupus will almost certainly hit that limit every year.

2. Verify Your Status: If you are on Medicaid, double-check that your medical records clearly reflect your lupus diagnosis to avoid any disruptions from new work-requirement audits. Ensure your rheumatologist has documented your "functional limitations" in your chart now, so you have evidence ready if you need to apply for a Medicaid work exemption.

3. Use the Tools: Explore the new TrumpRx portal and price transparency tools to see if your specific medications or regular lab tests are available at a lower rate nearby.

This is a mere glimpse into the complexities of what is on the horizon for healthcare in the USA in the coming year(s). It is important to continue these conversations with your medical providers, insurance carriers, and health advocates to ensure you do not get lost in the navigation of this big shift.

Compiled By:

Kelli (Casas) Roseta

**All resources provided by this blog are for informational purposes only, not to replace the advice of a medical professional. Kelli encourages you to always contact your medical provider with any specific questions or concerns regarding your illness. All intellectual property and content on this site and in this blog are owned by morethanlupus.com. This includes materials protected by copyright, trademark, or patent laws. Copyright, More Than Lupus 2026.

Sources:

• TrumpRx.gov (Official Portal): TrumpRx.gov

• White House Fact Sheet (Feb 2026): Launch of TrumpRx.gov and MFN Pricing Details

• HHS.gov – MAHA Initiative: Make America Healthy Again (MAHA) Overview

• CMS.gov – MAHA ELEVATE Model: New Lifestyle Medicine Model for Chronic Disease

•  4 "Big, Beautiful Bill" Changes Reshaping Care in 2026

• KFF (Kaiser Family Foundation): Mapping the Burden of Rising ACA Premiums

• Managed Healthcare Executive: SOTU 2026: Healthcare Highlights and Transparency Rules

• Orthorexia - an obsession with clean eating?

• Takeaways from Trump's State of the Union speech : NPR

• What Is the Most Favored Nation Model? And Why Is It Scary For Lupus Patients?